Cell-free DNA methylation and its potential as a biomarker in liquid biopsy: A systematic review
Clinica Chimica Acta · 2025-08 · 576 · 120403
DOI: 10.1016/j.cca.2025.120403 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinica Chimica Acta, 2025-08. Verfasst von Min Pan und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China; Stat…. Hauptthemen laut MEDLINE: DNA Methylation, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 113 Literaturangaben. Gefördert von: Open Research Fund of Southeast University and Jiangsu Province Hospital, Southeast University, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
DNA methylation is a critical epigenetic modification that regulates gene expression. Changes in cell-free DNA (cfDNA) methylation typically precede the clinical manifestations of diseases. Trace amounts in body fluid samples, fragmented feature, and high background noise are the challenges to be addressed before implementation of cfDNA methylation assay in clinical application. With advances in genomic analysis and methylation detection technologies, analysis of cfDNA methylation has emerged as a promising biomarker for early diagnosis, prognostic prediction, and tracing tissue origin. The tissue-specific methylation patterns of cfDNA further facilitate the determination of its tissue of origin, making cfDNA methylation invaluable in liquid biopsies. This review highlights the advanced technologies to analyze methylated cfDNA, summarizes the recent progress of cfDNA methylation assays in clinical applications, and underscores the value of the integration of cfDNA methylation with multi-omics analysis in future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China; State Key Laboratory of Digital Medical Engineering, School of Medicine, S…
- State Key Laboratory of Digital Medical Engineering, School of Medicine, Southeast University, Nanjing, China.
- State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China.
- State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China. Electronic address: jtu@seu.edu.cn.
Förderung
- Open Research Fund of Southeast University and Jiangsu Province Hospital
- Southeast University
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Pan, M., Cheng, X., Chen, H., Feng, Y., Ma, Z., Ge, Q., & Tu, J. (2025). Cell-free DNA methylation and its potential as a biomarker in liquid biopsy: A systematic review. Clinica Chimica Acta, 576, 120403. https://doi.org/10.1016/j.cca.2025.120403
Vancouver
Pan M, Cheng X, Chen H, Feng Y, Ma Z, Ge Q, et al. Cell-free DNA methylation and its potential as a biomarker in liquid biopsy: A systematic review. Clinica Chimica Acta. 2025;576:120403. doi:10.1016/j.cca.2025.120403
BibTeX
@article{Pan2025,
author = {Pan, Min and Cheng, Xinling and Chen, Huike and Feng, Yuxian and Ma, Zeyu and Ge, Qinyu and Tu, Jing},
title = {Cell-free DNA methylation and its potential as a biomarker in liquid biopsy: A systematic review},
journal = {Clinica Chimica Acta},
year = {2025},
volume = {576},
pages = {120403},
doi = {10.1016/j.cca.2025.120403}
}
EUVIMED